132 related articles for article (PubMed ID: 3512715)
21. Murine Ia-associated invariant chain's processing to complex oligosaccharide forms and its dissociation from the I-Ak complex.
Holt GD; Swiedler SJ; Freed JH; Hart GW
J Immunol; 1985 Jul; 135(1):399-407. PubMed ID: 3873494
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
Spiro RC; Sairenji T; Humphreys RE
J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
[TBL] [Abstract][Full Text] [Related]
23. Rapid nonlysosomal degradation of assembled HLA class II glycoproteins incorporating a mutant DR alpha-chain.
Koppelman B; Cresswell P
J Immunol; 1990 Oct; 145(8):2730-6. PubMed ID: 2212658
[TBL] [Abstract][Full Text] [Related]
24. [HLA-DR antigens: cellular expression and molecular structure].
Charron DJ
Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
[TBL] [Abstract][Full Text] [Related]
25. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
26. A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain.
Neumann J; Koch N
J Cell Sci; 2006 Oct; 119(Pt 20):4207-14. PubMed ID: 16984974
[TBL] [Abstract][Full Text] [Related]
27. A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain.
Ashman JB; Miller J
J Immunol; 1999 Sep; 163(5):2704-12. PubMed ID: 10453012
[TBL] [Abstract][Full Text] [Related]
28. Invariant chain influences post-translational processing of HLA-DR molecules.
Schaiff WT; Hruska KA; Bono C; Shuman S; Schwartz BD
J Immunol; 1991 Jul; 147(2):603-8. PubMed ID: 2071896
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of peptide binding to DR molecules by a leupeptin-induced invariant chain fragment.
Demotz S; Danieli C; Wallny HJ; Majdic O
Mol Immunol; 1994 Aug; 31(12):885-93. PubMed ID: 8065372
[TBL] [Abstract][Full Text] [Related]
30. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
Henne C; Schwenk F; Koch N; Möller P
Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
[TBL] [Abstract][Full Text] [Related]
31. Lack of detectable endocytosis of B lymphocyte MHC class II antigens using an antibody-independent technique.
Davis JE; Cresswell P
J Immunol; 1990 Feb; 144(3):990-7. PubMed ID: 2295824
[TBL] [Abstract][Full Text] [Related]
32. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
33. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.
Newcomb JR; Cresswell P
J Immunol; 1993 Jan; 150(2):499-507. PubMed ID: 8419482
[TBL] [Abstract][Full Text] [Related]
34. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
Long EO; LaVaute T; Pinet V; Jaraquemada D
J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
[TBL] [Abstract][Full Text] [Related]
35. HLA-D region antigen-associated invariant polypeptides as revealed by two-dimensional gel analysis. Glycosylation and structural inter-relationships.
Rudd CE; Bodmer JG; Bodmer WF; Crumpton MJ
J Biol Chem; 1985 Feb; 260(3):1927-36. PubMed ID: 2981878
[TBL] [Abstract][Full Text] [Related]
36. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
[TBL] [Abstract][Full Text] [Related]
37. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
[TBL] [Abstract][Full Text] [Related]
38. Separation of three class II antigens from a homozygous human B cell line.
Shackelford DA; Lampson LA; Strominger JL
J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185
[TBL] [Abstract][Full Text] [Related]
39. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
Wilson KM; Labeta MO; Pawelec G; Fernandez N
Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
[TBL] [Abstract][Full Text] [Related]
40. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
Stang E; Guerra CB; Amaya M; Paterson Y; Bakke O; Mellins ED
J Immunol; 1998 May; 160(10):4696-707. PubMed ID: 9590215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
